Evidence map›Paper›PMID 41350612›Full record

ArticleBMC primary care2025

Impact of the MHRA safety update on vitamin B

Ian Parsonage, David Wainwright, Julian Barratt

Abstract read
In one paragraph

Article in BMC primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ian ParsonageDepartment of Health, University of Bath, Bath, UK. ibp25@bath.ac.uk.
David WainwrightDepartment of Health, University of Bath, Bath, UK.
Julian BarrattAston Medical School, Aston University, Birmingham, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetformin is the most commonly prescribed oral treatment for type 2 diabetes mellitus (T2DM) in the UK. Long-term therapy has been linked to vitamin B

methodsA retrospective quantitative analysis was conducted using Read code data from 148,000 electronic medical records across three Primary Care Networks (PCNs) in the Southwest of England. Vitamin B

resultsAmong patients prescribed metformin, vitamin B

conclusionsThis study demonstrated that the release of the MHRA Drug Safety Update was associated with a modest but statistically significant increase in vitamin B

Indexed as

Clinical CodingDiabetes Mellitus, Type 2Hypoglycemic AgentsMetforminVitamin B 12Vitamin B 12 DeficiencyAgedElectronic Health RecordsEnglandFemaleHumansMaleMiddle AgedPrimary Health CareRetrospective StudiesUnited KingdomHypoglycemic AgentsMetforminVitamin B 12AwarenessClinicianDeficiencyHealthcare professionalKnowledgeMetforminScreeningVitamin B12

Identifiers

PMID41350612
PMCPMC12924288

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.